Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 19 Neoplasms 7 Osteosarcoma 5 Gastrointestinal Stromal Tumors 4 Neuroblastoma 3 Melanoma 3 Uterine Cervical Neoplasms 2 Testicular Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Lung Neoplasms 2 Glioma 2 Esophageal Neoplasms 2 Desmoid Tumors 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Somatostatinoma 1 Skin Neoplasms 1 Sarcoma, Myeloid 1 Sarcoma, Ewing 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplastic Cells, Circulating 1

Interventions

Doxorubicin 25 Radiotherapy 16 Ifosfamide 14 Trabectedin 10 pazopanib 6 ribociclib 5 pembrolizumab 5 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 Gemcitabine 5 Biopsy 5 palbociclib 4 Radiation 4 Docetaxel 4 Chemotherapy, Adjuvant 4 selinexor 3 liposomal doxorubicin 3 eribulin 3 abemaciclib 3 X-Rays 3 Vincristine 3 Neoadjuvant Therapy 3 Imatinib Mesylate 3 Filgrastim 3 Etoposide 3 Cyclophosphamide 3 toripalimab 2 temsirolimus 2 romidepsin 2 pegfilgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × Blood Specimen Collection × Sarcoma × Clear all

NCT04224064 2025-02-12

ESPACE

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting

Liposarcoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡